Formycon AG
XETRA:FYB
Balance Sheet
Balance Sheet Decomposition
Formycon AG
Formycon AG
Balance Sheet
Formycon AG
| Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Cash & Cash Equivalents |
1
|
0
|
0
|
1
|
0
|
1
|
3
|
5
|
7
|
22
|
42
|
25
|
10
|
27
|
42
|
|
| Cash Equivalents |
1
|
0
|
0
|
1
|
0
|
1
|
3
|
5
|
7
|
22
|
42
|
25
|
10
|
27
|
42
|
|
| Short-Term Investments |
3
|
2
|
0
|
10
|
9
|
20
|
11
|
11
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
3
|
3
|
4
|
11
|
5
|
5
|
8
|
12
|
15
|
28
|
31
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
3
|
3
|
4
|
11
|
5
|
5
|
8
|
12
|
15
|
28
|
31
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
9
|
23
|
22
|
|
| Total Current Assets |
4
|
2
|
0
|
11
|
13
|
23
|
19
|
27
|
19
|
28
|
50
|
38
|
31
|
67
|
95
|
|
| PP&E Net |
0
|
0
|
4
|
3
|
3
|
3
|
3
|
3
|
3
|
4
|
9
|
8
|
12
|
12
|
15
|
|
| PP&E Gross |
0
|
0
|
0
|
3
|
3
|
3
|
0
|
3
|
3
|
4
|
9
|
8
|
12
|
12
|
15
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
1
|
2
|
0
|
3
|
3
|
4
|
5
|
6
|
7
|
8
|
10
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
488
|
508
|
444
|
|
| Goodwill |
0
|
0
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
45
|
45
|
0
|
|
| Note Receivable |
0
|
3
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
21
|
21
|
24
|
279
|
258
|
218
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
45
|
45
|
0
|
|
| Total Assets |
4
N/A
|
6
+31%
|
6
+7%
|
15
+157%
|
17
+9%
|
27
+61%
|
25
-7%
|
31
+22%
|
40
+29%
|
54
+35%
|
81
+50%
|
71
-12%
|
854
+1 107%
|
890
+4%
|
772
-13%
|
|
| Liabilities | ||||||||||||||||
| Accounts Payable |
0
|
0
|
3
|
2
|
2
|
1
|
0
|
2
|
3
|
2
|
5
|
8
|
11
|
16
|
17
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
3
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
22
|
22
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
3
|
3
|
2
|
0
|
1
|
16
|
29
|
12
|
|
| Total Current Liabilities |
0
|
0
|
3
|
3
|
3
|
1
|
1
|
4
|
6
|
4
|
8
|
10
|
51
|
69
|
34
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
4
|
28
|
8
|
9
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
120
|
123
|
102
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
0
|
1
|
0
|
0
|
299
|
188
|
165
|
|
| Total Liabilities |
0
N/A
|
0
+119%
|
3
+648%
|
3
-7%
|
4
+19%
|
2
-40%
|
3
+24%
|
5
+87%
|
6
+21%
|
5
-16%
|
14
+156%
|
15
+8%
|
497
+3 253%
|
388
-22%
|
310
-20%
|
|
| Equity | ||||||||||||||||
| Common Stock |
4
|
5
|
5
|
9
|
9
|
9
|
9
|
9
|
9
|
10
|
11
|
11
|
15
|
16
|
18
|
|
| Retained Earnings |
0
|
1
|
3
|
4
|
4
|
16
|
13
|
16
|
24
|
38
|
56
|
45
|
2
|
74
|
52
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
343
|
413
|
496
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
4
N/A
|
5
+26%
|
3
-50%
|
12
+379%
|
13
+7%
|
25
+90%
|
22
-10%
|
26
+14%
|
33
+30%
|
48
+45%
|
67
+39%
|
56
-16%
|
357
+538%
|
503
+41%
|
462
-8%
|
|
| Total Liabilities & Equity |
4
N/A
|
6
+31%
|
6
+7%
|
15
+157%
|
17
+9%
|
27
+61%
|
25
-7%
|
31
+22%
|
40
+29%
|
54
+35%
|
81
+50%
|
71
-12%
|
854
+1 107%
|
890
+4%
|
772
-13%
|
|
| Shares Outstanding | ||||||||||||||||
| Common Shares Outstanding |
7
|
7
|
7
|
9
|
9
|
9
|
9
|
9
|
9
|
10
|
11
|
11
|
15
|
16
|
18
|
|